FDA Science and Research Tracking Fellowship
*Applications will be reviewed on a rolling-basis.
A research opportunity is available in the Office of Translational Sciences - Immediate Office, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA) in Silver Spring, Maryland or Jefferson, Arkansas. Based on pandemic response, participant may be able to participate from an alternate location on a temporary basis. However, at the time when Mentors and FDA Staff return to their usual on-site work schedule, participants will no longer be able to conduct training from an off-site location and will be expected to report to the site in Silver Spring, Maryland or Jefferson, Arkansas.
CDER performs an essential public health task by making sure that safe and effective drugs are available to improve the health of people in the United States. As part of the FDA, CDER regulates over-the-counter and prescription drugs, including biological therapeutics and generic drugs. This work covers more than just medicines.
The project will develop additional tools to mine and analyze the SARITA (CDER Science and Research Investment Tracking Archive) database, utilizing Natural Language Processing (NLP) approaches. This effort will help us to strategically identify intersecting interests and quantify project alignment with CDER strategic priorities and objectives. We will use a similar approach to catalog FDA-NIH scientific interactions, including FDA-NIH co-authored publications in 2015-2021.
Under the guidance of the mentor, the participant will evaluate and quantify scientific collaborations by CDER offices; FDA-NIH scientific interactions. In addition, the participant will be able to identify areas of shared interest and potential collaboration.
This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for six months, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at FDA in the Silver Spring, Maryland, or Jefferson, Arkansas, areas. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.
If you have questions, send an email to ORISE.FDA.CDER@orau.org. Please include the reference code for this opportunity in your email.